Discover undervalued stocks with Eulerpool.

Subscribe for $2

Patrys Stock PAB.AX

Price

0.00
Today +/-
+0
Today %
+0 %

Patrys stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Patrys stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Patrys stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Patrys stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Patrys's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Patrys Stock Price History

DatePatrys Price
10/3/20250.00 undefined
10/2/20250.00 undefined
9/30/20250.00 undefined
9/29/20250.00 undefined
9/26/20250.00 undefined
9/25/20250.00 undefined
9/24/20250.00 undefined
9/23/20250.00 undefined
9/22/20250.00 undefined
9/22/20250.00 undefined
9/19/20250.00 undefined
9/18/20250.00 undefined
9/17/20250.00 undefined
9/17/20250.00 undefined
9/16/20250.00 undefined
9/15/20250.00 undefined
9/15/20250.00 undefined
9/12/20250.00 undefined
9/11/20250.00 undefined
9/10/20250.00 undefined
9/9/20250.00 undefined
9/8/20250.00 undefined

Patrys Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Patrys, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Patrys from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Patrys’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Patrys. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Patrys’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Patrys’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Patrys’s growth potential.

Patrys Revenue, EBIT and net profit per share

DatePatrys RevenuePatrys EBITPatrys Net Income
2025828,500 undefined-2.71 M undefined-3.01 M undefined
20241.39 M undefined-3.54 M undefined-3.54 M undefined
20232.85 M undefined-7.06 M undefined-7.06 M undefined
20223.33 M undefined-6.78 M undefined-6.78 M undefined
20211.34 M undefined-4.06 M undefined-4.06 M undefined
2020772,800 undefined-2.75 M undefined-2.75 M undefined
2019844,400 undefined-3.41 M undefined-411,300 undefined
2018520,500 undefined-2.5 M undefined-2.5 M undefined
2017531,700 undefined-1.88 M undefined-1.06 M undefined
2016864,800 undefined-1.13 M undefined-1.08 M undefined
2015952,200 undefined-4.76 M undefined-8.47 M undefined
2014760,000 undefined-7.28 M undefined-7.29 M undefined
2013980,000 undefined-3.72 M undefined-3.53 M undefined
20121.07 M undefined-5.1 M undefined-5.11 M undefined
20111.07 M undefined-7.4 M undefined-7.42 M undefined
2010940,000 undefined-8.1 M undefined-7.54 M undefined
20091.43 M undefined-9.82 M undefined-8.66 M undefined
20081.11 M undefined-7.25 M undefined-7.32 M undefined
200760,000 undefined-1.62 M undefined-1.65 M undefined

Patrys Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (B)
DOCUMENTS
2007200820092010201120122013201420152016201720182019202020212022202320242025
0110110000000013210
---------------200.00-33.33-50.00-
-200.00200.00-200.00200.00--------100.00100.00100.00200.00-
0000000000000013200
-1-7-8-7-7-5-3-7-8-1-1-20-2-4-6-7-3-3
-600.0014.29-12.50--28.57-40.00133.3314.29-87.50-100.00--100.0050.0016.67-57.14-
0.080.170.180.20.240.340.550.620.720.740.780.951.081.081.622.762.92.92.91
- - - - - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Patrys Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Patrys is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (k)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (k)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (k)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (k)
OTHER SHORT-TERM LIAB. (k)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (k)
DEFERRED TAXES (M)
OTHER LIAB. (k)
LONG-T. LIABILITIES (k)
DEBT (M)
TOTAL CAPITAL (M)
2007200820092010201120122013201420152016201720182019202020212022202320242025
                                     
2.3215.239.66.786.26.195.238.674.663.221.914.616.473.9810.929.824.052.240.74
00020000000025.225.2740.668052.752.7000
000.120.480.04000000.480.62001.223.362.8400
0000000000000000000
0.390.760.220.110.090.160.150.080.020.060.082.10.140.180.210.290.240.230.17
2.7115.999.947.576.336.355.388.754.683.282.497.357.354.8412.413.537.132.470.91
60640830680480380290250805.94.35.66.43.63.93.71.74.30
1.032.8600000000000000000
000000000000001.223.362.8400
3.564.178.418.068.046.616.135.7400.710.660.620.570.530.480.440.390.350
0000000000000000000
0000000000000000000
4.657.679.248.748.526.996.425.990.080.710.670.620.580.531.713.83.240.350
7.3623.6619.1816.3114.8513.3411.814.744.7643.167.977.935.3814.1117.3310.362.820.91
                                     
6.5731.5834.6839.6345.0849.1450.7159.6859.6860.0460.0467.0467.0767.0978.1185.7285.7385.7386.01
0000000000000000000
-1.57-8.6-16.97-24.35-31.53-36.58-39.88-47.2-55.66-56.38-57.36-59.73-59.77-62.19-66.04-72.29-78.89-82.26-85.28
0010-50-80-110-60-50-40-18.5-13.7-19.70-18.8-34.6-4.3-4.200
0000000000000000000
522.9817.7215.2313.4712.4510.7712.433.983.642.667.297.34.8812.0413.436.843.470.73
0.490.60.810.761.20.720.932.140.670.540.420.570.480.310.630.160.290.240.14
000000008051.364.986141.8160.2218.2233.1265.1317.677.7
620250420190801901201900000000148.1131.4132.7792.5
0000000000000000000
1.030.010.020000000000000000
2.140.861.250.951.280.911.052.330.750.60.480.660.620.470.850.540.690.691.01
020010000000000000000
0000000000000000000
2200200100100040406025.215.521.216.4250002.60
22020200110100040406025.215.521.216.4250002.60
2.360.881.451.061.380.911.092.370.810.620.50.680.640.50.850.540.690.691.01
7.3623.8619.1716.2914.8513.3611.8614.84.794.263.167.977.935.3812.8913.977.524.161.74
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Patrys provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Patrys's financial health and stability.

Assets

Patrys's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Patrys must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Patrys after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Patrys's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (k)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (k)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
20072008200920102011201220132014201520162017201820192020202120222023
00000000000000-4-6-7
00000000000000000
00000000000000000
01101100201030013
00000000000000000
00000000000000000
00000000000000000
-1-7-7-7-5-3-2-5-4-1-1-20-2-3-8-5
-1-1-1-10000000000000
-2,000-3,000-2,000-1,0000000000-2,0001,0000-4,0001,0001,000
-1-1000000000-220-411
00000000000000000
1,0000000000000000000
5253554190007001170
6233454180006001170
--1.00---------------
00000000000000000
14-14-10-6-4-4-2-10-3-30-2-5-1-8-13
-2.9-8.91-8.65-8.05-6.03-4.14-2.86-5.16-4.26-1.54-1.28-2.09-0.13-2.5-3.88-8.68-5.78
00000000000000000

Patrys stock margins

The Patrys margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Patrys. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Patrys.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Patrys's sales revenue. A higher gross margin percentage indicates that the Patrys retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Patrys's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Patrys's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Patrys's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Patrys. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Patrys's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Patrys Margin History

Patrys Gross marginPatrys Profit marginPatrys EBIT marginPatrys Profit margin
202599.93 %-327.05 %-363.71 %
202499.93 %-253.85 %-253.85 %
202399.93 %-247.61 %-247.61 %
202299.89 %-203.4 %-203.4 %
2021100.12 %-303.56 %-303.56 %
202099.93 %-355.65 %-355.65 %
201999.93 %-403.99 %-48.71 %
201899.93 %-479.79 %-479.79 %
201799.93 %-353.86 %-198.97 %
201699.93 %-130.92 %-124.98 %
201599.93 %-499.47 %-889.56 %
201499.93 %-957.89 %-959.21 %
201399.93 %-379.59 %-360.2 %
201299.93 %-476.64 %-477.57 %
201199.93 %-691.59 %-693.46 %
201099.93 %-861.7 %-802.13 %
200999.93 %-686.71 %-605.59 %
200899.93 %-653.15 %-659.46 %
200799.93 %-2,700 %-2,750 %

Patrys Stock Sales Revenue, EBIT, Earnings per Share

The Patrys earnings per share therefore indicates how much revenue Patrys has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Patrys earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Patrys's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Patrys’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Patrys's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Patrys Revenue, EBIT and net profit per share

DatePatrys Sales per SharePatrys EBIT per sharePatrys Earnings per Share
20250 undefined-0 undefined-0 undefined
20240 undefined-0 undefined-0 undefined
20230 undefined-0 undefined-0 undefined
20220 undefined-0 undefined-0 undefined
20210 undefined-0 undefined-0 undefined
20200 undefined-0 undefined-0 undefined
20190 undefined-0 undefined-0 undefined
20180 undefined-0 undefined-0 undefined
20170 undefined-0 undefined-0 undefined
20160 undefined-0 undefined-0 undefined
20150 undefined-0.01 undefined-0.01 undefined
20140 undefined-0.01 undefined-0.01 undefined
20130 undefined-0.01 undefined-0.01 undefined
20120 undefined-0.02 undefined-0.02 undefined
20110 undefined-0.03 undefined-0.03 undefined
20100 undefined-0.04 undefined-0.04 undefined
20090.01 undefined-0.06 undefined-0.05 undefined
20080.01 undefined-0.04 undefined-0.04 undefined
20070 undefined-0.02 undefined-0.02 undefined

Patrys business model

The company Patrys Ltd is a biotechnology company based in Perth, Australia. It was founded in 2001 by a team of scientists and investors with the aim of developing and marketing targeted cancer treatments. Patrys focuses on the development of monoclonal antibodies and peptides containing therapeutic agents for cancer treatment. The main business model of Patrys is to develop and market new treatment options for cancer patients. The company utilizes the latest advancements in cancer research to develop innovative therapies tailored to the specific characteristics of each type of cancer. Patrys collaborates with leading scientists, research organizations, and pharmaceutical companies to develop a comprehensive portfolio of cancer treatments. Patrys has different business areas, all focused on the development of cancer treatments. One of these areas is the field of monoclonal antibodies, where Patrys concentrates on developing antibodies that can recognize and target specific proteins in cancer tissue. Another area focuses on the development of peptides specifically tailored to cancer cells. Patrys' products cover a variety of cancer types, including lung cancer, breast cancer, prostate cancer, colorectal cancer, and leukemia. The company's leading product is currently the antibody therapeutic PAT-LM1, used for the treatment of lung cancer. PAT-LM1 is a monoclonal antibody that targets a specific protein in the tumor, effectively combating the disease. The drug is currently in phase II clinical trials and showing promising results. Patrys is a company operating in a growing market. The global demand for cancer treatments is increasing, and Patrys has established itself as a significant player in this field. The company has gained recognition in recent years for its innovative therapy approaches and strong research and development team. Patrys aims to provide cancer patients with real hope for a cure and improve their quality of life. Overall, Patrys is a company operating in a rapidly growing market with a promising future. The company has developed a wide range of cancer treatments and works closely with leading experts and pharmaceutical companies to strengthen its position as an innovative and relevant player in cancer research. Patrys has a clear vision that it pursues, presenting an opportunity to play a significant role in the near future in a rapidly growing and highly relevant market. Patrys is one of the most popular companies on Eulerpool.com.

Patrys SWOT Analysis

Strengths

Patrys Ltd possesses several strengths that contribute to its success:

  • Strong brand reputation and recognition
  • Highly skilled and experienced workforce
  • Diversified product portfolio
  • Efficient supply chain management
  • Effective marketing and promotional strategies

Weaknesses

Despite its strengths, Patrys Ltd also faces certain weaknesses that need to be addressed:

  • Limited market presence in certain regions
  • Relatively higher production costs compared to competitors
  • Dependence on a few key suppliers
  • Slow adoption of new technologies
  • Inefficient internal communication processes

Opportunities

Patrys Ltd can capitalize on the following opportunities to further enhance its growth:

  • Expanding into emerging markets with high demand
  • Introduction of innovative products or services
  • Partnerships or collaborations with complementary businesses
  • Increasing consumer awareness and demand for sustainable products
  • Growing e-commerce market and online sales potential

Threats

Patrys Ltd should be cautious about the following threats that may impact its business:

  • Intense competition within the industry
  • Changes in government regulations or policies
  • Economic downturn or recession
  • Rapidly evolving market trends and consumer preferences
  • Potential supply chain disruptions
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Patrys Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Patrys historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Patrys shares outstanding

The number of shares was Patrys in 2024 — This indicates how many shares 2.897 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Patrys earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Patrys's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Patrys’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Patrys's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Patrys.

Patrys shareholders

%
Name
Stocks
Change
Date
4.42976 % Calder (Dax Marcus)129,000,000800,0008/14/2024
3.39182 % Stork Holdings 2010 Limited98,773,81498,773,8143/31/2025
2.23205 % Dax Calder Pty. Ltd.65,000,00008/14/2024
2.04939 % Marusic (Mladen)59,680,8432,207,8608/14/2024
1.81998 % Altum Trustees Ltd.52,999,988-1,549,8948/14/2024
1.36719 % Kemast Investments Pty. Ltd.39,814,27208/14/2024
1.21904 % Estelleanne Pty. Ltd.35,500,00008/14/2024
1.06452 % Marginata Proprietary Limited31,000,00008/14/2024
0.92716 % Staffwear Pty. Ltd.27,000,00008/14/2024
0.74568 % Towns Corporation Pty. Ltd.21,715,0006,232,0408/14/2024
1
2
3

Patrys Executives and Management Board

Dr. James Campbell

Patrys Chief Executive Officer, Managing Director, Executive Director (since 2014)
Compensation 718,035

Dr. Deanne Greenwood

Patrys Vice President - Business Development & Intellectual Property
Compensation 146,291

Mr. Michael Stork

Patrys Non-Executive Deputy Chairman of the Board (since 2007)
Compensation 5,002

Dr. Charmaine Gittleson

Patrys Chairman of the Board (since 2022)

Ms. Valentina Dubljevic

Patrys Vice President - Research and Development
1
2

Most common questions regarding Patrys

What values and corporate philosophy does Patrys represent?

Patrys Ltd represents values and a corporate philosophy centered around innovation, collaboration, and commitment to improving patients' lives. The company fosters a culture of scientific excellence, aiming to develop breakthrough antibody therapies for cancer treatment. Patrys Ltd is driven by a patient-centric approach, striving to make a meaningful difference in cancer patients' outcomes through novel and targeted solutions. With a strong focus on research and development, Patrys Ltd is dedicated to advancing the field of oncology and delivering innovative therapies to address unmet medical needs. This commitment underscores Patrys Ltd's passion for improving the lives of cancer patients worldwide.

In which countries and regions is Patrys primarily present?

Patrys Ltd is primarily present in Australia.

What significant milestones has the company Patrys achieved?

Patrys Ltd has achieved several significant milestones in its history. Firstly, the company successfully completed its initial public offering (IPO) and got listed on the stock exchange, which allowed it to raise capital for growth and expansion. Additionally, Patrys Ltd has made remarkable breakthroughs in its research and development activities, leading to the development of innovative and potentially impactful therapies. This includes the advancement of its lead drug candidate, PAT-DX1, which has shown promising results in preclinical studies. Furthermore, Patrys Ltd has established strategic collaborations with renowned research institutions and pharmaceutical companies, further validating its scientific expertise and creating potential opportunities for future success.

What is the history and background of the company Patrys?

Patrys Ltd is a biotechnology company founded in 2006 and headquartered in Melbourne, Australia. The company focuses on the development of novel antibodies for the treatment of cancer. Patrys Ltd has a strong research and development pipeline, aiming to create innovative and targeted therapies to address unmet medical needs in oncology. With a diverse portfolio of intellectual property, Patrys Ltd has achieved significant milestones and collaborations with leading industry partners. The company is dedicated to advancing its cutting-edge technologies and bringing new and effective cancer treatments to patients worldwide.

Who are the main competitors of Patrys in the market?

The main competitors of Patrys Ltd in the market include other companies operating in the biotechnology and pharmaceutical industries. These competitors may include well-established firms with a similar focus on developing innovative therapies and drugs. However, it is essential to conduct thorough market research to determine the specific competitors relevant to Patrys Ltd's offerings and target market. Stay updated with Patrys Ltd's latest announcements and industry news to gather accurate information about its current competitors.

In which industries is Patrys primarily active?

Patrys Ltd is primarily active in the biotechnology industry.

What is the business model of Patrys?

The business model of Patrys Ltd is focused on developing and commercializing innovative cancer therapies. Patrys is a biotechnology company that specializes in the development of antibodies for the treatment of cancer and other diseases. The company's key focus is on advancing its proprietary platform technology, PAT-SMART™, which aims to create novel therapies targeting a range of cancers. Patrys collaborates with leading research institutions and experts to develop and test its drug candidates. Through its business model centered around research and development, Patrys aims to bring novel therapies to market that have the potential to improve patient outcomes in the field of oncology.

What is the P/E ratio of Patrys 2025?

The Patrys P/E ratio is -1.93.

What is the P/S ratio of Patrys 2025?

The Patrys P/S ratio is 7.03.

What is the Quality Investing of Patrys?

The Quality Investing for Patrys is 2/10.

What is the revenue of Patrys 2025?

The Patrys revenue is 828,500 AUD.

How high is the profit of Patrys 2025?

The Patrys profit is -3.01 M AUD.

What is the business model of Patrys

Patrys Ltd is a biopharmaceutical company specializing in the discovery, development, and commercialization of antibodies against cancer and other diseases. Founded in 2000, the company is headquartered in Australia and has offices in the USA and Europe. Patrys' business model includes multiple divisions focused on product development and commercialization in various areas. The first division of Patrys focuses on the research and development of antibodies against cancer. The company utilizes its patented technologies to discover novel antibodies specifically targeting cancer cells. These discoveries are then further developed to assess safety and efficacy in clinical trials, with the goal of bringing them to market as new treatment options. Another division of Patrys is the manufacturing and commercialization of antibodies against autoimmune diseases such as Multiple Sclerosis (MS) and rheumatoid arthritis (RA). Patrys' developments in this area aim to identify specific antibodies that inhibit autoimmune reactions without suppressing the immune system overall. The company works closely with leading academics and clinicians to evaluate the efficacy of the developed antibodies and collect extensive clinical data. Thirdly, Patrys has a division for the development of therapeutic antibodies against infectious diseases such as Hepatitis B and C, as well as HIV. The company collaborates closely with scientists and experts in this field to develop antibodies that can directly bind to specific viral proteins and inhibit their spread. In addition to these main divisions, Patrys is also involved in licensing its technologies and know-how to other companies and research institutions. The company has an extensive patent portfolio relating to the discovery of cancer-targeting antibodies and immune-regulatory proteins. These patents are valuable to other biopharmaceutical companies and research institutions pursuing similar developments. Patrys also produces a range of diagnostic products used for the detection and monitoring of cancer and autoimmune diseases. These tests are developed and marketed in collaboration with other companies and institutions. Overall, Patrys' business model is focused on the discovery and development of novel antibodies and biological therapeutics against cancer, autoimmune diseases, and infectious diseases. These developments are valuable both for clinical practice and for licensing to other companies. Patrys aims to continuously expand and optimize its portfolio of diagnostics and therapeutics in collaboration with leading scientists and clinicians.

What is the Patrys dividend?

Patrys pays a dividend of 0 AUD distributed over payouts per year.

How often does Patrys pay dividends?

The dividend cannot currently be calculated for Patrys or the company does not pay out a dividend.

What is the Patrys ISIN?

The ISIN of Patrys is AU000000PAB9.

What is the Patrys WKN?

The WKN of Patrys is A0MU4Y.

What is the Patrys ticker?

The ticker of Patrys is PAB.AX.

How much dividend does Patrys pay?

Over the past 12 months, Patrys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Patrys is expected to pay a dividend of 0 AUD.

What is the dividend yield of Patrys?

The current dividend yield of Patrys is .

When does Patrys pay dividends?

Patrys pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Patrys?

Patrys paid dividends every year for the past 0 years.

What is the dividend of Patrys?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Patrys located?

Patrys is assigned to the 'Health' sector.

Wann musste ich die Aktien von Patrys kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Patrys from 10/5/2025 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 10/5/2025.

When did Patrys pay the last dividend?

The last dividend was paid out on 10/5/2025.

What was the dividend of Patrys in the year 2024?

In the year 2024, Patrys distributed 0 AUD as dividends.

In which currency does Patrys pay out the dividend?

The dividends of Patrys are distributed in AUD.

All fundamentals about Patrys

Our stock analysis for Patrys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Patrys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.